Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
11.36
-0.74 (-6.16%)
Oct 8, 2026, 10:58 AM EDT - Market open
Turn Therapeutics Market Cap
Turn Therapeutics has a market cap or net worth of $338.24 million as of October 8, 2026. It is the 17,181st most valuable company in the world and the 3,029th biggest in the United States.
Market Cap
338.24M
Enterprise Value
334.08M
1-Year Change
n/a
Global Rank
Country Rank
#3,029 United States
Category
ChartMarket Cap Chart
Since October 8, 2025, Turn Therapeutics's market cap has increased from $196.16M to $338.24M, an increase of 72.43%. That is a compound annual growth rate of 72.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 338.24M | 191.55% |
| Dec 31, 2025 | 116.01M | -40.86% |
| Oct 8, 2025 | 196.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 377.32M |
| vTv Therapeutics | 376.84M |
| Agenus | 376.37M |
| Zura Bio | 372.78M |
| C4 Therapeutics | 370.31M |
| Relmada Therapeutics | 366.94M |
| Orchestra BioMed Holdings | 366.64M |
| Opus Genetics | 366.06M |